Genoil (GNOLF) Change in Accured Expenses (2020 - 2025)
Historic Change in Accured Expenses for Genoil (GNOLF) over the last 6 years, with Q3 2025 value amounting to $8115.0.
- Genoil's Change in Accured Expenses rose 1577.97% to $8115.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $31508.0, marking a year-over-year increase of 1866.53%. This contributed to the annual value of $28206.0 for FY2024, which is 9574.19% down from last year.
- Per Genoil's latest filing, its Change in Accured Expenses stood at $8115.0 for Q3 2025, which was up 1577.97% from $7792.0 recorded in Q2 2025.
- Over the past 5 years, Genoil's Change in Accured Expenses peaked at $877067.0 during Q4 2022, and registered a low of $3945.0 during Q3 2022.
- In the last 5 years, Genoil's Change in Accured Expenses had a median value of $8115.0 in 2024 and averaged $177807.8.
- Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 239252.04% in 2021, then crashed by 9926.33% in 2023.
- Quarter analysis of 5 years shows Genoil's Change in Accured Expenses stood at $429885.0 in 2021, then skyrocketed by 104.02% to $877067.0 in 2022, then plummeted by 99.26% to $6461.0 in 2023, then rose by 25.6% to $8115.0 in 2024, then changed by 0.0% to $8115.0 in 2025.
- Its last three reported values are $8115.0 in Q3 2025, $7792.0 for Q2 2025, and $7486.0 during Q1 2025.